Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial

PURPOSE: To assess whether combination therapy (CT) reduces retreatments when compared to ranibizumab monotherapy (RM), while safely maintaining similar vision outcomes. METHODS: In this 24-month trial, patients with age-related macular degeneration (AMD) were randomized to 1) quarter-fluence or 2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallemore, Ron P, Wallsh, Josh, Hudson, Henry L, Ho, Allen C, Chace, Richard, Pearlman, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279866/
https://www.ncbi.nlm.nih.gov/pubmed/28182161
http://dx.doi.org/10.2147/OPTH.S119510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279866/
https://www.ncbi.nlm.nih.gov/pubmed/28182161
http://dx.doi.org/10.2147/OPTH.S119510

Ejemplares similares